Table 3. Pathways of target genes from the 40 miRNAs differentially expressed between tumor and healthy tissue of colorectal cancer patients.
KEGG pathway | P value1 | Genes2 | miRNAs3 |
---|---|---|---|
Prion diseases | <0.0001 | 1 | 2 |
Morphine addiction | <0.0001 | 44 | 10 |
Mucin type O-Glycan biosynthesis | <0.0001 | 13 | 7 |
ECM-receptor interaction | <0.0001 | 26 | 8 |
Fatty acid biosynthesis | <0.0001 | 5 | 1 |
Signaling pathways regulating pluripotency of stem cells | <0.0001 | 70 | 8 |
TGF-beta signaling pathway | <0.0001 | 38 | 8 |
GABAergic synapse | 0.0001 | 28 | 8 |
Axon guidance | 0.0001 | 68 | 6 |
Thyroid hormone signaling pathway | 0.0006 | 34 | 7 |
Proteoglycans in cancer | 0.0007 | 64 | 5 |
Glioma | 0.0050 | 28 | 7 |
FoxO signaling pathway | 0.0131 | 56 | 5 |
Prolactin signaling pathway | 0.01325 | 42 | 7 |
Estrogen signaling pathway | 0.02071 | 24 | 4 |
Renal cell carcinoma | 0.0211 | 28 | 5 |
1Only pathways with P values lower than 0.05 were considered as significant
2Number of genes affected in the pathway by the regulated miRNAs
3Number of miRNAs differentially expressed that have a target gene in the pathway